News for NxStage Medical, Inc. - Google Finance

NXSTAGE MEDICAL, INC. : NxStage Announces Second Quarter 2013 Investor ...

Thu, 09 May 2013 12:03:51 GMT

NXSTAGE MEDICAL, INC. : NxStage Announces Second Quarter 2013 Investor ...
4-traders (press release) - May 9, 2013

LAWRENCE, Mass. , May 9, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank , Chief Executive Officer, will participate in the following schedule of ...

NXSTAGE MEDICAL, INC. : NxStage Announces FDA Clearance for New High ...

Tue, 30 Apr 2013 12:02:49 GMT

NXSTAGE MEDICAL, INC. : NxStage Announces FDA Clearance for New High ...
4-traders (press release) - Apr 30, 2013

"This latest regulatory milestone reflects strong and systematic execution against our product pipeline," said Jeffrey Burbank, Chief Executive Officer, NxStage Medical, Inc. "With this new capability, NxStage therapy may be prescribed less frequently ...

NXSTAGE MEDICAL, INC. : NxStage Reports First Quarter 2013 Financial Results

Thu, 02 May 2013 11:36:36 GMT

NXSTAGE MEDICAL, INC. : NxStage Reports First Quarter 2013 Financial Results
4-traders (press release) - May 2, 2013

LAWRENCE, Mass., May 2, 2013 /PRNewswire/ -- NxStage(®) Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported first quarter financial results with revenue at the upper end of its guidance range.

NxStage Medical's CEO Discusses Q1 2013 Results - Earnings Call Transcript - Seeking Alpha

NXSTAGE MEDICAL, INC. : NxStage Names Robert G. Funari Chairman Of The ...

Thu, 25 Apr 2013 20:39:28 GMT

NXSTAGE MEDICAL, INC. : NxStage Names Robert G. Funari Chairman Of The ...
4-traders (press release) - Apr 25, 2013

LAWRENCE, Mass., April 25, 2013 /PRNewswire/ -- NxStage Medical, Inc.(®) (NASDAQ: NXTM) announced today that Robert G. Funari has been appointed as the non-executive Chairman of the Board effective immediately.

NxStage Announces New Agreements with DaVita

Tue, 21 May 2013 21:10:12 GMT

NxStage Announces New Agreements with DaVita
PR Newswire (press release) - May 21, 2013

LAWRENCE, Mass., May 21, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it has entered into new agreements covering its supply of home, critical care and ...

Nxstage Medical Price Target Lowered to $16.50 at Canaccord Genuity (NXTM)

Fri, 03 May 2013 23:42:52 GMT

Nxstage Medical Price Target Lowered to $16.50 at Canaccord Genuity (NXTM)
Daily Political - May 3, 2013

Analysts at Feltl & Co. raised their price target on shares of Nxstage Medical from $11.50 to $12.00 in a research note to investors on Friday.

Nxstage Medical Given New $16.50 Price Target at Canaccord Genuity (NXTM)

Tue, 07 May 2013 15:45:21 GMT

Nxstage Medical Given New $16.50 Price Target at Canaccord Genuity (NXTM)
Zolmax - May 7, 2013

NxStage Medical, Inc. (NASDAQ: NXTM) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures.

NxStage signs new dialysis supply agreements with DaVita

Wed, 22 May 2013 14:52:17 GMT

NxStage signs new dialysis supply agreements with DaVita
NephrologyNews.com - 20 hours ago

Dialysis product manufacturer NxStage Medical Inc. has signed new supply agreements with DaVita for home dialysis, critical care, and in-center dialysis supplies.

Nephrology And Urology Devices Market (Dialysis Equipment, Lithotripsy ...

Tue, 30 Apr 2013 12:09:28 GMT

Nephrology And Urology Devices Market (Dialysis Equipment, Lithotripsy ...
Wall Street Journal (press release) - Apr 30, 2013

22 Nxstage Medical Inc: Annual Revenue, USD Million, 2009 - 2011. FIG. 23 Nipro Corporation: Annual Revenue, USD Million, 2009 - 2011.

US/Canada daily earnings hits & misses May 02 - 0800 ET

Thu, 02 May 2013 12:06:29 GMT

US/Canada daily earnings hits & misses May 02 - 0800 ET
Globe and Mail - May 2, 2013

The figures are provided by Thomson Reuters I/B/E/S. **** Company Name Ticker Qtr Industry Curr EPS Est EPS Act Diff EPS Rev Est Rev Act Diff Rev ABIOMED INC Q4 MEDICAL SUPPLIES USD 0.07 0.09 0.02 42.0 43.7 1.7 ACI WORLDWIDE INC Q1 ... 1456.9 1359.9 ...